Vivek Subbiah: My first time inside Gustave Roussey in Paris France

Vivek Subbiah shared a post on LinkedIn:

“My first time inside Gustave Roussey in Paris France.
Such an honor to meet & get a tour of all the amazing facilities with the only & only Dr. Fabrice Andre on the day of the major announcement that he was awarded the Giants of Cancer Award – American Society of Clinical Oncology (ASCO) INSERM
Looking forward to deliver the keynote lecture on Precision Medicine 2030 at the IHU Prism Center today”

Source: Vivek Subbiah/LinkedIn

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research at the MD Anderson Cancer Network and a former Associate Professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center.

Dr. Vivek Subbiah has served as the principal investigator in over 100 phase I/II trials and co-investigator in over 200 clinical trials and is known for his leadership in several first-in-human and practice-changing studies that directly led to approvals from the FDA, European Medicines Agency, and other agencies across the world. He is an expert in tumor agnostic precision oncology and leads the BRAF and RET tissue agnostic studies to FDA approval.
OncoDaily